SOURCE: Biodis


April 12, 2012 15:49 ET

Biodis Biotechnology Distributors Announces Exclusive Distribution Agreement With BioTD, S.A.

Company to Attend American Congress of Obstetricians and Gynecologists 60th Annual Meeting in San Diego, California (Booth # 733)

LITTLE ROCK, AR--(Marketwire - Apr 12, 2012) - Biodis, an international biotechnology distributor announced today that the company has entered into an exclusive agreement with BioTD, S.A. to distribute Citofem®, in North America, India, Africa and Asia.

"Citofem® is the next generation of liquid cytology," said Dr. Ladly Abraham, Chief Medical Officer of Biodis. "Citofem® requires no specialized machinery, ships in a complete kit and simply offers the greatest value in cervical cancer screening in the world today."

"We're very excited about this partnership with BioTD, and especially as it relates to the fight against cervical cancer. We have the best pap smear, test kit on the market today, and we're also the least expensive," Joe Chacko, President of Biodis.

Biodis will also be distributing additional products including RossRu™, SPB™ and others both domestically and internationally. "With the talent, passion and experience Biodis has for distributing superior products and providing quick, responsive service, we believe Biodis is the ideal partner to assist us in the sales and distribution of Citofem® worldwide," said Robin Wisovitch, CEO, BioTD. S.A.

About Biodis

Biodis is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care.

Our customers include hospitals, clinics, state health associations, group purchasing organizations, national and local pharmacies, manufacturers, and insurers.

Biodis is one of the emerging biotechnology distributors in the world. We act as one of the primary international distributors of multiple products produced by BioTD and other manufacturers.

Contact Information

  • For Additional information on this announcement, please contact:
    Kent Erickson
    (858) 945-3690
    email address: Email Contact
    Email Contact